Lessons from diversion studies and antibacterial interventions
Related Experiment Video
Updated: May 20, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Paul K Flanagan1, Barry J Campbell, Jonathan M Rhodes
1Gastroenterology, University of Liverpool, Liverpool, UK.
Abstract:
If bacteria cause IBD, then it should be possible to target the bacteria with therapies and cure or at least treat the disease. Discovery of a successful intervention, unless found by chance, will depend on knowing more about which bacteria are involved, where they are and how to remove them. Some evidence for the possible role of bacteria has come from in vivo studies of the effects of diverting the faecal stream away from sites of IBD. Alternative hypotheses arise from the diversion studies that could incriminate other components of the faecal stream that include bile acids and dietary components. Antibiotics will only really be adequately tested when we know what the target bacteria are and where they are, e.g. whether in the lumen or mucosa and whether intracellular or extracellular. Some encouraging responses have been observed, however, with empirical antibiotic therapy.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness
Urine Studies II: Urine Culture and Sensitivity Test
Clinical Significance of Antibiotic Resistance
Biological Methods for Microbial Control
Antibiotic Selection
